Robert Barrow - Net Worth and Insider Trading
Robert Barrow Net Worth
The estimated net worth of Robert Barrow is at least $58 Million dollars as of 2026-09-11. Robert Barrow is the CEO of Definium Therapeutics Inc and owns about 1,494,640 shares of Definium Therapeutics Inc (DFTX) stock worth over $58 Million. Details can be seen in Robert Barrow's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Barrow has not made any transactions after 2026-09-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Barrow
Robert Barrow Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Barrow owns 1 companies in total, including Definium Therapeutics Inc (DFTX) .
Click here to see the complete history of Robert Barrow’s form 4 insider trades.
Insider Ownership Summary of Robert Barrow
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| DFTX | Definium Therapeutics Inc | 2026-09-03 | director & Chief Executive Officer |
Robert Barrow Latest Holdings Summary
Robert Barrow currently owns a total of 1 stock. Robert Barrow owns 1,494,640 shares of Definium Therapeutics Inc (DFTX) as of September 3, 2026, with a value of $58 Million.
Latest Holdings of Robert Barrow
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DFTX | Definium Therapeutics Inc | 2026-09-03 | 1,494,640 | 38.89 | 58,126,550 |
Holding Weightings of Robert Barrow
Robert Barrow Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Barrow has made a total of 29 transactions in Definium Therapeutics Inc (DFTX) over the past 5 years, including 1 buys and 28 sells. The most-recent trade in Definium Therapeutics Inc is the sale of 19,023 shares on September 3, 2026, which brought Robert Barrow around $721,733.
Insider Trading History of Robert Barrow
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Robert Barrow Trading Performance
GuruFocus tracks the stock performance after each of Robert Barrow's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Barrow is 21.88%. GuruFocus also compares Robert Barrow's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Barrow within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Barrow's insider trading performs compared to the benchmark.
Performance of Robert Barrow
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.24 | | | | | |
| Relative Return to S&P 500(%) | -5.12 | | | | | |
Robert Barrow Ownership Network
Ownership Network List of Robert Barrow
Ownership Network Relation of Robert Barrow
Robert Barrow Owned Company Details
What does Definium Therapeutics Inc do?
Who are the key executives at Definium Therapeutics Inc?
Robert Barrow is the director & Chief Executive Officer of Definium Therapeutics Inc. Other key executives at Definium Therapeutics Inc include Chief Financial Officer Brandi Roberts , Chief Legal Officer Mark Sullivan , and Chief Commercial Officer Matthew T. Wiley .
Definium Therapeutics Inc (DFTX) Insider Trades Summary
Over the past 18 months, Robert Barrow made 7 insider transaction in Definium Therapeutics Inc (DFTX) with a net sale of 171,949. Other recent insider transactions involving Definium Therapeutics Inc (DFTX) include a net sale of 46,041 shares made by Dan Karlin , a net sale of 53,055 shares made by Mark Sullivan , and a net sale of 3,013 shares made by Brandi Roberts .
In summary, during the past 3 months, insiders sold 77,154 shares of Definium Therapeutics Inc (DFTX) in total and bought 0 shares, with a net sale of 77,154 shares. During the past 18 months, 279,272 shares of Definium Therapeutics Inc (DFTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 279,272 shares.
Definium Therapeutics Inc (DFTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Definium Therapeutics Inc Insider Transactions
Robert Barrow Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Barrow. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert Barrow's mailing address is: New York Ny 10007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
